Hoda E Mohamed

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Transforming Growth Factor

Chronic Kidney Disease

Epithelial Mesenchymal Transition

Top Venues

Journal of biochemical and molecular toxicology

The Journal of pharmacy and pharmacology

Journal of food biochemistry

Molecular and cellular biochemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Hoda E Mohamed, Mervat E Askar, Mohamed A Shaheen, Alaa E Salama, Reham A Idris, Nahla N Younis
Infliximab substantially re-silenced Wnt/β-catenin signaling and ameliorated doxorubicin-induced cardiomyopathy in rats. Journal of biochemical and molecular toxicology (2023)
Hoda E Mohamed, Mervat E Askar, Mohamed A Shaheen, Alaa E Salama, Reham A Idris, Nahla N Younis
Infliximab substantially re-silenced Wnt/β-catenin signaling and ameliorated doxorubicin-induced cardiomyopathy in rats. Journal of biochemical and molecular toxicology (2023)
Hoda E Mohamed, Mervat E Asker, Mohamed A Shaheen, Rana G Eissa, Nahla N Younis
Alleviation of fructose-induced Alzheimer's disease in rats by pioglitazone and decaffeinated green coffee bean extract. Journal of food biochemistry 45 (5) (2021)
Nahla N Younis, Hoda E Mohamed, Mohamed A Shaheen, Asmaa M Abdelghafour, Sally K Hammad
Potential therapeutic efficacy of pachymic acid in chronic kidney disease induced in rats: role of Wnt/β-catenin/renin-angiotensin axis. The Journal of pharmacy and pharmacology (2021)
Hoda E Mohamed, Mervat E Asker, Mohammed M Keshawy, Rehab A Hasan, Yasmin K Mahmoud
Inhibition of tumor necrosis factor-α enhanced the antifibrotic effect of empagliflozin in an animal model with renal insulin resistance. Molecular and cellular biochemistry 466 (1-2) (2020)